• Publications
  • Influence
The response of metastatic adenocarcinoma of the prostate to exogenous testosterone.
It is concluded that the response of patients with metastatic prostate cancer to exogenous testosterone is related to the mass and endocrine treatment status, and thatExogenous testosterone can stimulate prostatic neoplasms that proliferate in the absence of normal endogenous testosterone levels. Expand
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
This study shows that intravesical therapy with BCG delays tumor progression and death from tumor in patients who present with superficial bladder cancer. Expand
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
Mouse monoclonal antibodies were obtained by immunization with cultured human bladder cancer or lysates of bladder papilloma. They identify 11 distinct antigenic systems as defined by serologicalExpand
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse
Although 68% of CR patients have relapsed, CR median survival will exceed 38 months compared with 11 months for partial (36%) and minor (6%) responders, and 8 months for nonresponders: 2‐year and 3‐year survivals were 68% and 55%, respectively, versus 0% to 7% for the remaining patients. Expand
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
It is suggested that in high-risk patients intravesical BCG can delay disease progression, prolong the period of bladder preservation, and increase overall survival. Expand
Retropubic implantation to iodine 125 in the treatment of prostatic cancer.
The technique of retropubic implantation of 125I seeds in selected patients with prostatic cancer has resulted in more accurate tumor staging and produced an encouraging degree of local regression in clinically evident prostatic lesions during a brief period of followup. Expand
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
Evaluation of patients with superficial bladder carcinoma at 6 months after intravesical bacillus Calmette-Guerin therapy identifies the probability of tumor progression. Expand
Intermittent endocrine therapy for advanced prostate cancer
It is indicated that satisfactory palliation of advanced prostatic cancer can be achieved in selected patients using intermittent endocrine therapy. Expand
Penile cancer: relation of extent of nodal metastasis to survival.
A retrospective review of 199 patients with penile cancer revealed that the extent of inguinal nodal metastasis was related to survival after radical ilioinguinal dissection. Patients with unilateralExpand
Zinc Content of Expressed Human Prostatic Fluid
Higher zinc-levels have been reported in human spermatozoa, in human seminal plasma, and in 3 specimens of human carcinoid tissue (av. 1.702 mgm./gm). Expand